STAT+: Sage Therapeutics names former Alnylam exec Barry Greene as its new CEO
Sage Therapeutics is making a significant leadership change, hiring Barry Greene, the recently departed president of Alnylam Pharmaceuticals, as the biotech’s new chief executive officer.
Jeff Jonas, Sage’s CEO since 2013, will remain with the company as chief innovation officer. The official CEO handoff took place onTuesday and was made public on Wednesday morning.
